首页> 美国政府科技报告 >Final Report on the Developmental Toxicity of 8-Methoxypsoralen (CAS No. 298-81-7) in Sprague-Dawley (CD (Trade Name)) Rats on Gestational Days 6 through 15
【24h】

Final Report on the Developmental Toxicity of 8-Methoxypsoralen (CAS No. 298-81-7) in Sprague-Dawley (CD (Trade Name)) Rats on Gestational Days 6 through 15

机译:关于8-甲氧基补骨脂素(Cas号298-81-7)在sprague-Dawley(CD(商品名))大鼠妊娠第6至15天发育毒性的最终报告

获取原文

摘要

8-Methoxypsoralen is a naturally occurring linear furocoumarin that is foundprimarily in the families Umbelliferae, Rutaceae, and Moraceae. Psoralens inhibit DNA synthesis in the presence of long wavelength (320-400 nM) ultraviolet (UVA) light. This forms the basis for their therapeutic use as antiproliferative agents in skin diseases characterized by hyperproliferation of skin cells such as psoriasis. The current study was undertaken because little information exists on the potential for MOXY to be a reproductive or developmental toxicant. The widespread use of MOXY in the treatment of proliferative skin diseases and its ability to disrupt cell division make it potentially harmful to the developing fetus. Accordingly, the authors have examined the effects of MOXY (0, 20, 80, 120, and 160 mg/kg/day) administered by gavage to pregnant Sprague-Dawley (CD) rats on gestational days 6 through 15. The period of dosing corresponds to the period of major organogenesis in rats. They determined the effects of MOXY on maternal status and on fetal growth, viability, and morphological development by examining fetuses on gd 20 for external, visceral, and skeletal malformations.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号